Not all IP, just relating to a new end product. Leaves ANO positioned / focused as a wholesale level supplier rather than branching out into consumer supply, which is fair enough strategically as it means they are not in direct competition with other potential customers of the formulations.
Would think it's inappropriate to be done without an expert's report to support value given it's a related party transaction, but they may in fact have one of those (independent directors should have insisted on it).
Ann: $1.9 million Unaudited First Half Pre-tax Profit Result, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.065(6.31%) |
Mkt cap ! $68.59M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.10 | $1.03 | $5.569K | 5.228K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7087 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 11358 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| ANO (ASX) Chart |